Key result
Chronic PDGFRβ signaling drives VSMC apoptosis in plaque via PI3K-dependent c-Myc and Bcl-2 suppression.
Why the study?
Vascular smooth muscle cell apoptosis impacts atherosclerotic plaque growth and stability and is believed to be suppressed by growth factor-dependent PI3K activation. The effects of chronically elevated PDGFRβ signaling on VSMC apoptosis and aortic plaque composition during atherogenesis required analysis.
Does chronically elevated PDGFRβ signaling increase vascular smooth muscle cell apoptosis and alter aortic plaque composition in LDLR-/-smLRP1-/- mice?
Does chronically elevated PDGFRβ signaling increase vascular smooth muscle cell apoptosis and alter aortic plaque composition in LDLR-/-smLRP1-/- mice?
Chronically elevated PDGF signaling promotes vascular smooth muscle cell apoptosis in atherosclerotic plaques via a PI3K/c-Myc/Bcl-2 pathway, potentially contributing to fibrous cap thinning and plaque instability.
Background: Growth and stability of atherosclerotic plaques are impacted by vascular smooth muscle cell (VSMC) apoptosis which is believed to be suppressed by growth factor dependent activation of phosphoinositide 3-kinase (PI3K). Here, we analyzed the effects of chronically elevated platelet-derived growth factor receptor β (PDGFRβ) signaling on VSMC apoptosis and aortic plaque composition during atherogenesis. Methods: We assessed atherosclerosis in low-density lipoprotein receptor deficient mice, lacking low-density lipoprotein receptor-related protein 1 in VSMCs (LDLR-/-smLRP1-/- mice), in that smLRP1 deficiency resulted in PDGFRB overexpression. Apoptosis and downstream signaling was investigated in cultured aortic VSMCs. Results: Chronically elevated PDGFRβ signaling in LDLR-/-smLRP1-/- mice unexpectedly increased VSMC apoptosis in atherosclerotic plaques. In vitro, PDGF exerted transient anti-apoptotic effects on VSMCs, whereas long-term stimulation promoted cell death. Mutation of the PI3K binding site in the PDGFRβ (PDGFRβ-F2/F2) reduced VSMC apoptosis in plaques as well as in cultured VSMCs. Further analyses revealed that PI3K isoform p110α mediates VSMC survival, whereas p110δ and p110β rather promote apoptosis. We identified a pro-apoptotic PDGFRβ-driven signaling pathway in VSMCs involving PI3K-dependent induction of c-Myc that in turn suppresses the expression of anti-apoptotic Bcl-2. PDGF-dependent downregulation of Bcl-2 increases the susceptibility of VSMCs to apoptotic agonists like H2O2 or Fas ligand. Consistently, Bcl-2 expression was elevated in plaques from PDGFRβ-F2/F2 mice. Conclusions: Our study expands the understanding of the role of growth factors in regulating apoptosis and argues against their role as pure survival factors. This has direct implications in atherogenesis, as chronically elevated PDGF does not mediate VSMC survival in atherosclerotic plaques, but rather promotes cell death in the VSMC-rich fibrous cap, thus promoting plaque instability and rupture.
No takes yet. Share an insight, caveat, or question.
Vantler et al. (2026) studied Atherosclerosis. Chronically elevated PDGFRβ signaling and PI3K binding site mutation (PDGFRβ-F2/F2) vs. Control / wild-type PDGFRβ signaling was evaluated on Vascular smooth muscle cell (VSMC) apoptosis and aortic plaque composition. Chronically elevated PDGFRβ signaling increased VSMC apoptosis in atherosclerotic plaques via PI3K-dependent c-Myc induction and Bcl-2 suppression, which was reduced by PDGFRβ-F2/F2 mutation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: